| Product NDC: | 63010-027 |
| Proprietary Name: | VIRACEPT |
| Non Proprietary Name: | nelfinavir mesylate |
| Active Ingredient(s): | 625 mg/1 & nbsp; nelfinavir mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63010-027 |
| Labeler Name: | AGOURON PHARMACEUTICALS INC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021503 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030430 |
| Package NDC: | 63010-027-70 |
| Package Description: | 120 TABLET, FILM COATED in 1 BOTTLE (63010-027-70) |
| NDC Code | 63010-027-70 |
| Proprietary Name | VIRACEPT |
| Package Description | 120 TABLET, FILM COATED in 1 BOTTLE (63010-027-70) |
| Product NDC | 63010-027 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | nelfinavir mesylate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20030430 |
| Marketing Category Name | NDA |
| Labeler Name | AGOURON PHARMACEUTICALS INC |
| Substance Name | NELFINAVIR MESYLATE |
| Strength Number | 625 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |